Anticoagulation therapy given to prevent or treat venous thromboembolism (VTE) was linked to lower death rates in hospitalized adult COVID-19 patients, but the association remained at 60 days only for the prophylactic (preventive) strategy, according to a multicenter study today in JAMA Network Open.The study, led by University of Utah and University of Michigan researchers, involved a pseudorandom sample of 1,351 COVID-19 patients 18 years and older admitted to 30 Michigan hospitals from Mar 7 to Jun 17, 2020.
VTE, or blood clots that cause a blockage in the veins, is a leading complication of COVID-19, the authors noted.Compared with no anticoagulation, any dose of anticoagulation was tied to lower in-hospital death rates (aHR for